ERCOLE BIOTECH INC has a total of 21 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are CHARPENTIER EMMANUELLE, KINGSMAN ALAN JOHN and MAO YUMIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 16 | |
#2 | Canada | 1 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Medical preparations | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Sazani Peter L | 20 |
#2 | Kole Ryszard | 14 |
#3 | Orum Henrik | 12 |
#4 | Graziewicz Maria | 9 |
#5 | Ørum Henrik | 4 |
#6 | Oerum Henrik | 3 |
#7 | L Sazani Peter | 1 |
Publication | Filing date | Title |
---|---|---|
AU2016204703A1 | Soluble tnf receptors and their use in treatment of disease | |
AU2015202996A1 | Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease | |
AU2014200020A1 | Soluble tnf receptors and their use in treatment of disease | |
AU2012261660A1 | Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease | |
AU2007352163A1 | Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease | |
US2007249538A1 | Soluble TNF receptors and their use in treatment of disease | |
AU2007309650A1 | Soluble TNF receptors and their use in treatment of disease | |
AU2006315758A1 | Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease |